OrphaMed Selects IDBS’ Integrated Data Management System
News Nov 27, 2007
IDBS has announced that Spanish start-up biotechnology company, OrphaMed (Valladolid), has licensed ActivityBase Suite and E-WorkBook to manage its complete drug discovery workflow.
Focusing initially on research for new drug indications for haematological cancers, OrphaMed sought a comprehensive data management solution that could store all of its research data. ActivityBase XE and E-WorkBook, IDBS’ electronic laboratory notebook (ELN), integrate to deliver the level of flexibility demanded by OrphaMed’s scientists.
Juan Ballesteros, Chief Scientific Officer and Co-founder of OrphaMed, commented: “We required a solution that could easily manage all our diverse research data across three major research sites. Already being aware of ActivityBase and IDBS’ track record, we approached them looking for an integrated data management system.
ActivityBase XE’s superior flexibility is highly adaptable for our changing research needs and processes. Additionally, E-WorkBook will allow us to store all our research data and notes and comply with regulatory standards for clinical data in one secure environment, which will in turn lead to enhanced decision making.”
Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.READ MORE